CALABRESE, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 8.704
AS - Asia 7.436
EU - Europa 6.111
AF - Africa 493
SA - Sud America 413
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.172
Nazione #
US - Stati Uniti d'America 8.584
VN - Vietnam 2.106
SG - Singapore 1.999
CN - Cina 1.759
IT - Italia 1.377
GB - Regno Unito 1.252
DE - Germania 770
SE - Svezia 713
HK - Hong Kong 504
FR - Francia 391
IN - India 355
UA - Ucraina 317
BR - Brasile 301
RU - Federazione Russa 298
IE - Irlanda 239
NL - Olanda 171
CH - Svizzera 153
TG - Togo 134
JP - Giappone 128
ZA - Sudafrica 126
KR - Corea 118
CI - Costa d'Avorio 108
FI - Finlandia 94
JO - Giordania 85
EE - Estonia 77
BD - Bangladesh 70
BG - Bulgaria 63
CA - Canada 62
SC - Seychelles 54
PH - Filippine 53
AR - Argentina 47
TH - Thailandia 41
BE - Belgio 40
PL - Polonia 36
MX - Messico 32
TW - Taiwan 25
TR - Turchia 23
IQ - Iraq 22
RO - Romania 22
ID - Indonesia 21
AT - Austria 20
ES - Italia 20
IR - Iran 20
NG - Nigeria 19
GR - Grecia 18
PK - Pakistan 17
UZ - Uzbekistan 17
SA - Arabia Saudita 15
CL - Cile 14
EC - Ecuador 14
CO - Colombia 12
EG - Egitto 12
PY - Paraguay 9
AU - Australia 8
IL - Israele 8
TN - Tunisia 8
CZ - Repubblica Ceca 7
ET - Etiopia 7
KE - Kenya 7
LB - Libano 7
LT - Lituania 7
MA - Marocco 7
MY - Malesia 7
VE - Venezuela 7
AZ - Azerbaigian 6
HR - Croazia 5
PE - Perù 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
NP - Nepal 4
PT - Portogallo 4
DK - Danimarca 3
KZ - Kazakistan 3
QA - Qatar 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BH - Bahrain 2
CY - Cipro 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
MD - Moldavia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
Totale 23.152
Città #
Singapore 1.385
Southend 1.047
Ashburn 1.005
Fairfield 708
Chandler 705
San Jose 487
Hong Kong 480
Santa Clara 448
Ho Chi Minh City 414
Hanoi 387
Wilmington 353
Woodbridge 334
Houston 313
Seattle 306
Princeton 286
Ann Arbor 265
Beijing 255
Hefei 254
Cambridge 238
Dublin 238
Dong Ket 223
Jacksonville 198
Boardman 176
Bologna 169
Bern 136
Lauterbourg 134
Lomé 134
New York 122
Milan 121
Nanjing 115
Tokyo 111
Abidjan 108
Los Angeles 103
Westminster 102
Padova 99
Council Bluffs 90
Seoul 89
Berlin 85
Amman 84
Rome 78
Turin 78
Helsinki 76
Haiphong 73
Frankfurt am Main 67
Dallas 65
Buffalo 64
Sofia 63
San Diego 62
Jinan 57
Saint Petersburg 55
Shenyang 55
Guangzhou 54
Redondo Beach 50
São Paulo 50
Da Nang 49
Shanghai 46
Mülheim 45
Changsha 40
Munich 39
Brussels 38
London 37
Phoenix 34
Nanchang 33
Falkenstein 32
Tianjin 32
Bremen 30
Bengaluru 29
Hebei 29
Johannesburg 29
Medford 28
Des Moines 27
Biên Hòa 26
Redmond 26
Amsterdam 25
Zhengzhou 25
Washington 24
Atlanta 23
Chicago 22
Orem 22
Redwood City 22
Thái Nguyên 22
Can Tho 21
Jiaxing 21
Warsaw 21
San Francisco 20
Toronto 20
Brooklyn 19
Taizhou 19
Mahé 18
Nuremberg 18
Quận Bình Thạnh 18
Yubileyny 18
Abeokuta 17
Hangzhou 17
Naples 17
Taiyuan 17
Boston 16
Dearborn 16
Hải Dương 16
Montreal 16
Totale 14.433
Nome #
Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease. 523
Ulcerative Colitis 372
COVID-19 in IBD: The experience of a single tertiary IBD center 306
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 260
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 260
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 246
Erosions or not in GORD? The potential role of oesophageal cell proliferation 245
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 244
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 227
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 224
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 223
Implications of antioxidant protein in human gastric neoplasm 220
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 219
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 219
Ex vivo HR-MAS Magnetic Resonance Spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa 217
Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? 215
Attachment and quality of life in patients with inflammatory bowel disease 215
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 214
Palmitoylethanolamide (PEA) for Prevention of Gastroesophageal Inflammation: Insights from In Vitro Models 213
Endoscopic appearance of GERD: Putative role of cell proliferation 213
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 211
High-dose probiotics for the treatment of active pouchitis 210
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 210
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 209
Differential activity and expression of superoxide dismutase in human gastric neoplasm 208
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. 206
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 205
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 204
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 201
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 197
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 197
Acute Esophageal Necrosis. 197
Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. 197
Implications of antioxidant enzymes in human gastric neoplasms 195
Clinical course of microscopic colitis in a single-center cohort study 193
Mesalazine with or without cholestyramine in the treatment of microscopic colitis: Randomized controlled trial 192
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 192
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 192
Long-term management of GERD in the elderly with pantoprazole 191
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 191
Cytochrome P450 (CYP1A/1A2)and SODs expression in human gastric neoplasm 190
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 190
Erosions or not in GERD? The potential role of esophageal cell kinetics 189
Antibiotics and probiotics in treatment of inflammatory bowel disease 188
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 187
Management and treatment of distal ulcerative colitis 187
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 187
Oral budesonide in the treatment of chronic refractory pouchitis. 186
Identification of mobile lipids in human cancer tissues by ex vivo diffusion edited HR-MAS MRS 185
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 182
Role of conventional therapies in the era of biological treatment in Crohn's disease. 181
THE ROLE OF SOD, CAT AND CYP1A1/1A2 IN HUMAN GASTRIC NEOPLASM   180
Probiotics in IBD: A critical review 180
Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa 179
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 178
Role of Biologics in refractory pouchitis 178
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 177
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation 176
Cytochrome P450 (CYP 1A1/1A2) and SODs expression in human gastric neoplasm 175
The role of Budesonide-MMX in active ulcerative colitis. 174
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 173
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 172
Which therapies are advisable in pouchitis? 170
Capsule endoscopy revealing small-intestinal lymphangiectasia and GI stromal tumor polyps in neurofibromatosis type 1. 170
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 169
Pre-pouch ileitis 169
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. 167
Cytochrome P450 (CYP 1A1/1A2) expression and lipid profile in human gastric neoplasm 167
Intestinal Microbiota Increases Cell Proliferation of Colonic Mucosa in Human-Flora-Associated (HFA) Mice 166
Bifidobacteriaceae usually colonize human hypochloridric stomach 166
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 164
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 163
A current overview of corticosteroid use in active ulcerative colitis 163
Oral beclomethasone dipropionate in chronic refractory pouchitis 162
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 162
Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis 162
Discrimination of Healthy and Neoplastic Human Colon Tissues by ex Vivo HR-MAS NMR Spectroscopy and Chemometric Analyses 161
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 158
Rescue therapy: ciclosporin or infliximab? 157
Molecular characterization of human gastric mucosa by HR-MAS magnetic resonance spectroscopy 156
Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. 156
Probiotics, Prebiotics, and Antibiotics in IBD 155
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 154
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 154
Burden of illness in Italian patients with gastro-oesophageal reflux disease 153
The role of antibiotics and probiotics in pouchitis 151
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis 149
Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach 148
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 144
Capsule Endoscopy in the Detection of Non-Small Bowel Lesions Missed By Endoscopy 143
RISK OF SHORT TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS TREATED WITH AZATHIOPRINE FOR CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE 142
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 142
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 139
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis 137
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 136
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients 136
Colitis evolving into ulcerative colitis 136
Correlation between endoscopic features of gastric antrum, histology and Helicobacter pylori infection in adults 136
Dilated intercellular spaces as a marker of oesophageal damage: Comparative results in gastro-oesophageal reflux disease with or without bile reflux 136
Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR Spectroscopy and chemometric analyses. 134
Totale 18.900
Categoria #
all - tutte 64.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.765


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021661 0 0 0 0 0 0 0 0 0 0 0 661
2021/20222.611 210 88 182 181 251 140 66 172 103 193 628 397
2022/20233.153 286 454 156 375 219 254 109 168 577 59 233 263
2023/2024936 65 154 86 77 72 228 60 44 23 56 30 41
2024/20253.236 183 410 238 238 631 159 191 122 55 212 106 691
2025/20267.571 702 651 606 502 885 439 750 265 1.594 639 320 218
Totale 23.554